Immitra Bio raises $2.6M pre seed

◆ Amount

$2.6M

◆ Announced

21 Jul 2026

◆ Company

◆ Source

◆ The Round

Immitra Bio raised $2.6M in pre seed funding, announced on 21 July 2026, led by Backbone Ventures, OCCIDENT, with participation from Kickfund, Venture Kick, Zürcher Kantonalbank, FONGIT, ETH Foundation. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About Immitra Bio

Swiss biotech developing an in-vivo gene editing platform for inherited blood disorders. Immitra Bio is based in Switzerland and currently at pre seed stage, operating in deeptech, healthtech, gene-editing.

◆ Investors

◆ Market context

This funding event is a citable node in Fusion42's market graph: it links Immitra Bio's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market